BioCentury
ARTICLE | Clinical News

Interleukin-11: Began Phase III trial in 250 patients

November 13, 1995 8:00 AM UTC

Genetics Institute Inc. (GENIZ), Cambridge, Mass. Product: Interleukin-11 Indication: Restore platelet count after chemotherapy Status: Began Phase III trial in 250 patients ...